The External Assessment Group did a systematic review of the evidence on cost effectiveness for faecal calprotectin testing and constructed a de novo economic model. The outcomes of interest for the ...

A test that rapidly detects signs of inflammatory bowel disease (IBD) in stool samples could improve future diagnosis and ...

A test that rapidly detects signs of inflammatory bowel disease (IBD) in stool samples could improve future diagnosis and ...

University of Edinburgh scientists developed a luminescent reporter that detected granzyme A activity in stool samples, ...

A test that rapidly detects signs of inflammatory bowel disease (IBD) in stool samples could improve future diagnosis and ...

Researchers in Edinburgh have developed a rapid stool-based test aiming to improve the diagnosis of inflammatory bowel ...

Two biomarker tests -- one for blood and the other for stool -- are mainstays in the treatment of inflammatory bowel disease (IBD), but gastroenterologists are hoping to gain even more insight from ...

One method used to diagnose (or monitor) common inflammatory disorders, such as ulcerative colitis and Crohn’s disease, is to measure the amount of the protein calprotectin in stool samples. In ...

BÜHLMANN, a company based in Germany, launched IBDoc, an at-home, in-vitro diagnostic test for gastrointestinal conditions, including some inflammatory bowel diseases, according to an IBD News Today ...

CINCINNATI, Ohio — Meridian Bioscience’s European division will distribute in Italy a test for intestinal problems with plans to expand into France. The test, Quantum Blue Calprotectin, differentiates ...

The Diagnostics Advisory Committee discussed the focus of the evaluation and the evidence available for faecal calprotectin testing. It noted that evidence existed on faecal calprotectin testing in ...